Elsevier

Journal of Nuclear Cardiology

Volume 11, Issue 1, January–February 2004, Pages 71-86
Journal of Nuclear Cardiology

Major achievements in nuclear cardiology: II
Myocardial perfusion imaging agents: SPECT and PET

https://doi.org/10.1016/j.nuclcard.2003.12.002Get rights and content

Introduction

Myocardial perfusion imaging for the evaluation of regional myocardial blood flow and viability under rest or stress conditions has emerged as the major nuclear cardiology technique in clinical practice. The evolution of this technique over the years has occurred in parallel with advances in instrumentation, particularly with the transformation from planar gamma camera approaches to image acquisition to tomographic imaging with single photon emission computed tomography (SPECT) technology, which now can include gated acquisition for simultaneous assessment of function and attenuation correction for enhancing specificity with reduction in attenuation artifacts. Simultaneously, positron emission tomographic (PET) imaging has become more prevalent as an alternative approach to evaluating myocardial blood flow by use of positron-emitting radionuclides that are short-lived. Although current tracers used for perfusion imaging have provided valuable clinical information, further advances are needed to enhance the detection rate of coronary artery lesions as well as the capability of monitoring subtle changes in defect size with medical therapy aimed at alleviating stress-induced ischemia and/or improving coronary endothelial function.

Section snippets

Historical perspective

Potassium 43 (K-43) was one of the first radionuclides to be used for imaging in patients but was limited by its rather high-energy photons (373-keV peak) that made imaging with gamma cameras somewhat problematic. The tracer also had a 22.4-hour physical half-life, so studies had to be separated by a minimum of 4 days to reduce residual activity from the first procedure (eg, resting imaging). Images were obtained on a rectilinear scanner by use of planar anterior and oblique projections. When

Background

Assessment of myocardial perfusion is critical for evaluating the significance of diseases that affect the coronary artery and for evaluation of their severity. Although SPECT constitutes the primary modality for assessing myocardial perfusion with radioactive tracers, PET provides several significant advantages over SPECT imaging. These include accurate attenuation correction, because of the physical characteristics of the positron-emitting radionuclides, and the ability to quantify myocardial

Conclusions

The advent of myocardial perfusion imaging 30 years ago was a major landmark, which heralded the emergence of the field of nuclear cardiology into clinical practice. Over the years, the different tracers cited in this review have been used with SPECT or PET imaging technologies for the noninvasive evaluation of regional myocardial blood flow, which has enhanced our ability to diagnose CAD, assess prognosis, detect viable myocardium, and evaluate the efficacy of therapies aimed at improving

Acknowledgements

We acknowledge Ms Erika Laurion and Mr Jerry Curtis for assistance in the preparation of this review, as well as the contribution of our fellows and colleagues over the years.

The authors have indicated they have no financial conflicts of interest.

First page preview

First page preview
Click to open first page preview

References (83)

  • M.F. Di Carli et al.

    Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes

    J Am Coll Cardiol

    (2003)
  • K.L. Gould et al.

    Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82

    J Am Coll Cardiol

    (1986)
  • R.E. Stewart et al.

    Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease

    Am J Cardiol

    (1991)
  • H.R. Schelbert et al.

    Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography

    Am J Cardiol

    (1982)
  • Y. Yonekura et al.

    Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission computed tomography

    Am Heart J

    (1987)
  • A. Shah et al.

    Measurement of regional myocardial blood flow with N-13 ammonia and positron-emission tomography in intact dogs

    J Am Coll Cardiol

    (1985)
  • R.S. Beanlands et al.

    Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heartcomparison with rubidium 82 and copper 62-labeled PTSM

    J Nucl Cardiol

    (1994)
  • G.D. Hutchins et al.

    Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging

    J Am Coll Cardiol

    (1990)
  • S.R. Bergmann

    Cardiac positron emission tomography

    Semin Nucl Med

    (1998)
  • S.R. Bergmann et al.

    Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography

    J Am Coll Cardiol

    (1989)
  • M.N. Walsh et al.

    Augmented myocardial perfusion reserve after coronary angioplasty quantified by positron emission tomography with H2(15)O

    J Am Coll Cardiol

    (1990)
  • E.M. Geltman et al.

    Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries

    J Am Coll Cardiol

    (1990)
  • B.L. Zaret et al.

    Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris

    N Engl J Med

    (1973)
  • D.S. Berman et al.

    Noninvasive detection of regional myocardial ischemia using rubidium-81 and the scintillation cameracomparison with stress electrocardiography in patients with arteriographically documented coronary stenosis

    Circulation

    (1975)
  • H.W. Strauss et al.

    Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion

    Circulation

    (1975)
  • H.F. Weich et al.

    The extraction of thallium-201 by the myocardium

    Circulation

    (1977)
  • C.A. Moore et al.

    Thallium 201 kinetics in stunned myocardium characterized by severe postischemic systolic dysfunction

    Circulation

    (1990)
  • J.A. Leppo et al.

    Separate effects of ischemia, hypoxia, and contractility on thallium-201 kinetics in rabbit myocardium

    J Nucl Med

    (1986)
  • D. McCall et al.

    Kinetics of thallium exchange in cultured rat myocardial cells

    Circ Res

    (1985)
  • D.D. Watson et al.

    Overview of kinetics and modeling

  • G.M. Pohost et al.

    Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201

    Circulation

    (1977)
  • G.A. Beller et al.

    Time course of thallium-201 redistribution after transient myocardial ischemia

    Circulation

    (1980)
  • A.M. Grunwald et al.

    Myocardial thallium-201 kinetics in normal and ischemic myocardium

    Circulation

    (1981)
  • B.C. Berger et al.

    Quantitative thallium-201 exercise scintigraphy for detection of coronary artery disease

    J Nucl Med

    (1981)
  • V. Dilsizian et al.

    Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging

    N Engl J Med

    (1990)
  • G.M. Pohost et al.

    Thallium redistribution in dogs with severe coronary artery stenosis of fixed caliber

    Circ Res

    (1981)
  • P. Kailsanath et al.

    Technetium-99m-labeled myocardial perfusion agentsare they better than thallium-201?

    Cardiol Rev

    (2001)
  • D.K. Glover et al.

    Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole

    Circulation

    (1990)
  • D.K. Glover et al.

    Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity

    Circulation

    (1995)
  • R.C. Marshall et al.

    Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout, and retention at varying coronary flow rates in rabbit heart

    Circulation

    (1990)
  • D. Piwnica-Worms et al.

    Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence

    Circulation

    (1990)
  • Cited by (76)

    • Imaging biomarkers for cardiovascular diseases

      2019, Handbook of Medical Image Computing and Computer Assisted Intervention
    • Novel radiopharmaceuticals in cardiovascular medicine: Present and future

      2014, Journal of Medical Imaging and Radiation Sciences
    • Characterization of the four isomers of <sup>123</sup>I-CMICE-013: A potential SPECT myocardial perfusion imaging agent

      2014, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      However, these radiotracers have certain suboptimal pharmacokinetic characteristics. 201Tl SPECT MPI has poor image quality in obese patients, redistribution to non-target tissues over time, and fair radiodosimetry.2,5 A shortcoming with both 99mTc MPI agents and 201Tl is the disproportional low myocardial uptake under stress conditions with myocardial hyperaemia (the ‘roll-off’ phenomenon).2,8–10

    View all citing articles on Scopus
    View full text